Given that NCR- ILC3s secrete higher amounts of IL-17A and were implicated in HCC progression, we can speculate that TGF-β may participate to liver tumorigenesis by mediating ILC2 and ILC3 plasticity. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.